Beigani

About this medicine

Originator: Alunbrig by ARIAD Pharmaceuticals · Manufacturer: TLPH Pharma. Indication & Dosage: Beigani (Brigatinib), generic ALUNBRIG/Alanbrig is the prescription medicine used to treat anaplastic lymphoma kinase-positive (LUCIBRIGA+) metastatic non-small cell lung cancer (NSCLC) that has spread to other parts of the body. Beigani Manufactured by TLPH Pharma ltd. in Laos. Brigatinib has to take orally once a day with or without food. After the first 7 days if tolerated, healthcare provider may increase dose to 180 mg orally once daily. Side Effects: The most common adverse reactions of Brigatinib are: Nausea / vomiting , diarrhea , decreased appetite, abdominal pain, constipation, tiredness, dizziness , fever, headache , trouble sleeping, or joint pain. The above information comes from the Internet. Please consult with doctor for medical advice.

This information is provided for reference only and is not medical advice. Always consult a qualified healthcare professional.